Seeing the Problem, the XR Simulation

Macular disease poses a significant global challenge, emerging as a leading cause of sight loss. The prevalence is striking, with an estimated 288 million people projected to be affected by 2040. In the US alone, nearly 11 million individuals grapple with AMD, a number expected to double by 2050, affecting people of all ages. While a cure for AMD remains elusive, the urgency to raise awareness is undeniable.
Recognizing the pressing need to address this challenge, Roche, a global leader in Pharmaceuticals and Diagnostics, partnered with Lucid Reality Labs to pioneer a groundbreaking solution using Extended Reality (XR) technology. The result is "Seeing the Problem," The Extended Reality (XR) Ophthalmology Macular Disease Simulation. It transcends conventional approaches and, for the first time in the history of Ophthalmology, allows healthcare practitioners, medical students, and patient associations to gain firsthand insights into the daily struggles of those living with macular disease.

Developed using Varjo XR-3, one of the most advanced mixed reality headsets, the XR experience provides real-time simulations of AMD conditions. Users can empathize with the symptoms, from visual distortions to increased blurriness of printed words and a well-defined blind spot in their field of vision. The XR solution becomes an invaluable resource for early diagnosis and preventing the deterioration of the condition.
"Seeing the Problem" was presented to the UK Members of Parliament, where more than 50 members praised its effectiveness in conveying the challenges of disease. The subsequent #TheEyesHaveIt campaign gained traction, leading to strategic partnerships with the Macular Society and Fight for Sight organizations. This success raised awareness and initiated a dialogue on NHS capacity and access to treatment, advocating for policies to prevent avoidable sight loss.

Beyond its impact on eye health, the XR solution unveils the potential of immersive technology to address overlooked social problems. Aiming at improving the quality of lives, Roche's commitment to the "Eyes Have It" campaign marks a transformative step towards a more inclusive and informed future. The success achieved in the UK Parliament presentations positions the XR solution for global expansion, with plans for a further USA presentation.